New drug target for X-linked lymphoproliferative disease identified
An international team of scientists including researchers at St. Jude Children's Research Hospital have identified a crucial signaling enzyme as a possible therapeutic target for the treatment of a heritable immune disease. ...
Jan 13, 2016